GlassScriptPhysician profile
Thomac C Drake
NPI 1588761431
$2,484.25
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,215 · 2022: $1,109 · 2023: $146 · 2024: $13.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $160.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,105.60 | 2021-2024 | Relistor, Xifaxan |
| Abbvie INC. | $429.60 | 2021-2023 | |
| Almatica Pharma LLC | $153.35 | 2021-2023 | Gralise |
| Amgen INC. | $151.26 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $133.90 | 2021 | |
| Biodelivery Sciences International, INC. | $85.12 | 2021 | |
| Redhill Biopharma INC. | $81.13 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $75.43 | 2022 | |
| Arbor Pharmaceuticals, INC. | $45.72 | 2021 | |
| Virtus Pharmaceuticals LLC | $42.22 | 2021 | |
| Bioventus LLC | $34.68 | 2021 | |
| Horizon Therapeutics Plc | $34.07 | 2022-2023 | Krystexxa |
| Protega Pharmaceutials INC | $23.97 | 2023 | Roxybond |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.42 | 2022 | |
| Scilex Pharmaceuticals INC. | $18.79 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $18.03 | 2021 | |
| Allergan, INC. | $17.60 | 2021 | |
| Pfizer INC. | $12.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomac Drake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.